MedPath

Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology logo
🇺🇸United States
Ownership
Private
Established
2011-01-01
Employees
251
Market Cap
-
Website
https://www.allianceforclinicaltrialsinoncology.org

Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer

Completed
Conditions
Lung Cancer
Interventions
Other: laboratory biomarker analysis
First Posted Date
2012-01-25
Last Posted Date
2021-08-17
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
1060
Registration Number
NCT01517971
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

Phase 2
Active, not recruiting
Conditions
Colorectal Cancer
Interventions
Drug: FOLFOX (chemotherapy)
Other: 5 FUCMT (chemoradiation)
Procedure: surgery
Procedure: magnetic resonance imaging or endorectal ultrasound
First Posted Date
2012-01-24
Last Posted Date
2024-02-02
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
1194
Registration Number
NCT01515787
Locations
🇺🇸

Hematology and Oncology Associates, Chicago, Illinois, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

🇺🇸

John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States

and more 1065 locations

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

Phase 2
Active, not recruiting
Conditions
Lymphoma
Interventions
First Posted Date
2012-01-18
Last Posted Date
2021-08-17
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
113
Registration Number
NCT01511562
Locations
🇺🇸

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

🇺🇸

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

and more 123 locations

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202

Completed
Conditions
Lung Cancer
Interventions
Other: laboratory biomarker analysis
First Posted Date
2012-01-04
Last Posted Date
2021-08-17
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
23
Registration Number
NCT01503619
Locations
🇺🇸

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery

Phase 1
Completed
Conditions
Kidney Cancer
Liver Cancer
Interventions
Drug: hypoxia-activated prodrug TH-302
First Posted Date
2011-12-22
Last Posted Date
2020-02-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
24
Registration Number
NCT01497444
Locations
🇺🇸

Mayo Clinic Cancer Center, Rochester, Minnesota, United States

🇺🇸

Mayo Clinic Scottsdale, Scottsdale, Arizona, United States

Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Phase 1
Completed
Conditions
Lung Cancer
Interventions
Radiation: radiation therapy
First Posted Date
2011-12-06
Last Posted Date
2018-01-19
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
22
Registration Number
NCT01486602
Locations
🇺🇸

University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States

🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

🇺🇸

University of Chicago, Chicago, Illinois, United States

and more 8 locations

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer

Phase 1
Withdrawn
Conditions
Pancreatic Cancer
Interventions
Biological: ganitumab
Other: placebo
Other: questionnaire administration
First Posted Date
2011-11-17
Last Posted Date
2016-06-28
Lead Sponsor
Alliance for Clinical Trials in Oncology
Registration Number
NCT01473303

Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy

Phase 3
Withdrawn
Conditions
Diarrhea
Gastrointestinal Complications
Constipation, Impaction, and Bowel Obstruction
Cognitive/Functional Effects
Fatigue
Unspecified Adult Solid Tumor, Protocol Specific
Psychosocial Effects of Cancer and Its Treatment
Interventions
Dietary Supplement: live freeze-dried lactic acid bacteria probiotic
Other: placebo
First Posted Date
2011-11-17
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Registration Number
NCT01473290

Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Procedure: MRI
Procedure: conventional surgery
First Posted Date
2011-09-23
Last Posted Date
2018-03-27
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
108
Registration Number
NCT01439711
Locations
🇺🇸

Southern Ohio Medical Center, Portsmouth, Ohio, United States

🇺🇸

Missouri Baptist Medical Center, Saint Louis, Missouri, United States

🇺🇸

Bay Area Tumor Institute, Oakland, California, United States

and more 29 locations

Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Cancer Survivor
Hot Flashes
Interventions
Other: placebo
First Posted Date
2011-09-23
Last Posted Date
2017-04-04
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
289
Registration Number
NCT01439945
Locations
🇺🇸

Eureka Community Hospital, Eureka, Illinois, United States

🇺🇸

St. James Healthcare Cancer Care, Butte, Montana, United States

🇺🇸

Illinois CancerCare - Havana, Havana, Illinois, United States

and more 277 locations
© Copyright 2025. All Rights Reserved by MedPath